Global Proteomics Market is expected to increase during the forecast period at a substantial CAGR. Increased research activity, especially in the field of personalised medicine and drug development, is the primary driver of growth for this sector. In addition, increased R&D spending by pharmaceutical and biotechnology firms, increased government funding and technological developments are also driving market growth.
A full report of Proteomics Market available at: https://www.orionmarketreports.com/proteomics-market/10953/
Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Bruker Corporation (US), Danaher Corporation (US), GE Healthcare (US), Luminex Corporation (US), PerkinElmer Inc. (US), Waters Corporation (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN Bioinformatics (Netherlands), Creative Proteomics (US), Promega Corporation (US), Sengenics (Singapore), Biomax Informatics AG (Germany), MS Bioworks LLC (US), GENEWIZ (US), Biognosys AG (Switzerland), Bioproximity (SwitzerlandPoochon Scientific, LLC (US), Proteome Factory AG (Germany), VProteomics (India), HORIBA, Ltd. (Japan), and Applied Biomics, Inc. (US). In 2021, Thermo Fisher Scinetific (US) acquired Phitonex (US).In 2020, Perkin Elmer (US) launched SARS-COV-2 Antigen Elisa Test.In 2020, Bruker Corporation (US) acquired Integrated Proteomics Applications’ IP2 software.
Global Proteomics Market – Segmentation
By Instrumentation Technology
• Spectroscopy
o Mass Spectroscopy
o NMR Spectroscopy
o CD Spectroscopy
• Chromatography
o HPLC
o Ion Chromatography
o Affinity Chromatography
o Supercritical Fluid Chromatography
• Electrophoresis
o Gel Electrophoresis
o Capillary Electrophoresis
• Protein Microarrays
o Biochips
o Micrparray Instruments
• X – Ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation
By Reagent
• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X – Ray Crystallography Reagents
By Software & Service
• Core Proteomics Services
o Protein Identification Services
o Protein Characterization Services
o Quantitative Proteomic Services
o Protein Purification Services
• Bioinformatics Software & Services
o Bioinformatics Software
o Bioinformatics Tools
o Bioinformatics Databases
By Application
• Clinical Diagnostics
o Cancer
o Infectious Diseases
o Diabetes
o Neurological Disorders
o Immune Diseases
• Drug Discovery
o Target Discovery
o Lead Identification
o Lead Optimization
o Preclinical Studies
By End-User
• Hospitals
• Clinical Laboratories
• Pharmaceutical Companies
• Academic Research Laboratories
• Other End Users
Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Rest of the World
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
